DANVERS, Mass. (AP) _ Abiomed Inc. (ABMD) on Thursday reported fiscal second-quarter net income of $62.2 million.

On a per-share basis, the Danvers, Massachusetts-based company said it had profit of $1.36. Earnings, adjusted for non-recurring gains, were $1.01 per share.

The results exceeded Wall Street expectations. The average estimate of six analysts surveyed by Zacks Investment Research was for earnings of 87 cents per share.

The maker of heart devices posted revenue of $209.8 million in the period, also surpassing Street forecasts. Five analysts surveyed by Zacks expected $201.4 million.

For the current quarter ending in January, Abiomed said it expects revenue in the range of $221 million to $230 million.

Abiomed shares have climbed 66% since the beginning of the year. The stock has increased 54% in the last 12 months.

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on ABMD at https://www.zacks.com/ap/ABMD

Copyright by Automated Insights, Inc. All rights reserved., source Associated Press News